πŸ“˜ Chapter 104 Β· Clinical Manifestations of Genetic Metabolic Diseases

Nelson Textbook of Pediatrics 22nd Ed | Key tables: Neurologic & laboratory findings (Table 104.3), neonatal hypoglycemia (104.4), hyperammonemia DDx (104.5), hepatomegaly (104.6), cardiomyopathy (104.7), dysmorphic features (104.8), hydrops (104.9), physical exam findings (104.10), odors (104.11), clinical/lab red flags (104.12–13) and diagnostic algorithm.

🌐 paeds.online β€” Pakistan's Pediatric Platform

πŸ“‹ Table 104.3: Neurologic & Laboratory Manifestations in Neonates (IEM)

PresentationAssociated Disorders
Deterioration of consciousness + Metabolic acidosisOrganic acidemias, pyruvate metabolism defects, fatty acid oxidation defects, fructose-1,6-bisphosphatase deficiency, glycogen storage diseases, mitochondrial RC defects, ketone metabolism disorders
Hypoglycemia (see Table 104.4)Fatty acid oxidation defects, gluconeogenesis disorders, fructose/galactose disorders, glycogen storage diseases, hyperinsulinemic hypoglycemias, organic acidemias, mitochondrial RC defects, citrin deficiency, carbonic anhydrase VA deficiency
HyperammonemiaUrea cycle defects, organic acidemias, fatty acid oxidation defects, glycine encephalopathy, pyruvate carboxylase deficiency, GLUD1 hyperinsulinism, carbonic anhydrase VA deficiency, Zellweger spectrum
Seizures + HypotoniaCongenital disorders of glycosylation, antiquitin deficiency (pyridoxine-dependent epilepsy), purine/pyrimidine defects, PNPO deficiency
Neonatal ApneaGlycine encephalopathy (NKH), multiple carboxylase deficiency, urea cycle disorders, organic acidemias, fatty acid oxidation defects
πŸ”¬ Select IEM associated with key neonatal neurologic signs (adapted from Nelson Ch.104).

πŸ“‹ Table 104.4: Select IEM Associated with Neonatal Hypoglycemia

CategorySpecific Disorders
Fatty acid oxidation disordersCarnitine-acylcarnitine translocase, CPT-Ia, CPT-II, LCHAD, MTP deficiency, MCAD, VLCAD, multiple acyl-CoA dehydrogenase (GA2)
Disorders of ketone metabolismHMG-CoA lyase deficiency, HMG-CoA synthase deficiency, SCOT deficiency, Ξ²-ketothiolase deficiency
Gluconeogenesis defectsFructose-1,6-bisphosphatase, PEPCK deficiency
Glycogen storage diseasesGSD I (von Gierke), GSD III, GSD VI, GSD IX
Hyperinsulinemic hypoglycemiaHADH, GLUD1 (HI/HA), ABCC8/KCNJ11 (KATP channel), focal/diffuse HI
Organic acidemias / otherPropionic, methylmalonic, isovaleric, multiple carboxylase deficiency, mitochondrial RC defects, citrin deficiency

πŸ“‹ Table 104.5: Differential Diagnosis of Hyperammonemia

CategoryExamples
Urea cycle enzyme defectsNAGS, CPS1, OTC (X-linked most common), ASS (citrullinemia), ASL (argininosuccinic aciduria), arginase 1 deficiency
Organic acidemiasPropionic acidemia, methylmalonic acidemia, isovaleric acidemia
Fatty acid oxidation disordersLong-chain defects, CPT deficiencies, carnitine transporter defect
Other IEMPyruvate carboxylase deficiency, GLUD1 hyperinsulinism, carbonic anhydrase VA deficiency
Acquired / transientTransient hyperammonemia of newborn, liver failure, valproate toxicity, Reye syndrome

πŸ“‹ Table 104.6: Select Metabolic Disorders with Hepatomegaly

GroupDisorders
Amino acid disordersTyrosinemia type I, citrin deficiency, urea cycle defects
Carbohydrate disordersGalactosemia, hereditary fructose intolerance, GSD I, III, IV, VI, IX
Lysosomal storageGaucher, Niemann-Pick, mucopolysaccharidoses, I-cell disease
Fatty acid oxidationCarnitine defects, VLCAD, LCHAD, MADD (GA2)
Mitochondrial/PeroxisomalZellweger spectrum, respiratory chain defects

πŸ“‹ Table 104.7: IEM Associated with Cardiomyopathy

Disorder CategoryExamples
Glycogen storage diseasesGSD II (Pompe), GSD III, PRKAG2, GSD IV
Fatty acid oxidationCACT deficiency, CPT-II, LCHAD/MTP, VLCAD, ACAD9, carnitine transporter defect
Lysosomal storageFabry disease, Danon disease (LAMP2), MUCOpolysaccharidoses
Mitochondrial RC defectsmtDNA mutations, SCO2, TMEM70, CoQ10 deficiency

πŸ“‹ Table 104.8: Dysmorphic Features in IEM

Disorder GroupExamples
Congenital disorders of glycosylation (CDG)PMM2-CDG, ALG3-CDG, Walker-Warburg
Lysosomal storageMucopolysaccharidoses (coarse facies), oligosaccharidoses, sphingolipidoses
Cholesterol biosynthesisSmith-Lemli-Opitz, desmosterolosis, Conradi-HΓΌnermann
Peroxisomal disordersZellweger spectrum (high forehead, large fontanelle, flat face)

πŸ“‹ Table 104.11: Peculiar Odors in IEM

OdorDisorder
β€œSweaty feet” / acridIsovaleric acidemia, glutaric acidemia type II
Maple syrup / burnt sugarMaple syrup urine disease (MSUD)
Mousey / mustyPhenylketonuria (PKU)
Boiled cabbage / rancid butterTyrosinemia type I, hypermethioninemia
Cat urineMultiple carboxylase deficiency (biotinidase/holocarboxylase synthetase)
Rotten fishTrimethylaminuria, dimethylglycine dehydrogenase deficiency

πŸ”„ Initial Clinical Approach to a Full-Term Newborn with Suspected IEM (based on Nelson Fig. 104.2)

Step 1: Clinical suspicion β€” Unexplained sepsis-like picture, lethargy, vomiting, seizures, hypotonia, respiratory distress.

Step 2: First-line STAT labs β€” Plasma ammonia, glucose, electrolytes, blood gas (pH, HCO3), lactate, urine ketones, and urine reducing substances.

Step 3: Decision tree

  • πŸ”Ή Hyperammonemia + normal pH/alkalosis β†’ Urea cycle defect (OTC, CPS1, ASS, ASL). Treat with IV glucose, ammonia scavengers, arginine, consider dialysis.
  • πŸ”Ή Hyperammonemia + metabolic acidosis + ketosis β†’ Organic acidemia (propionic, methylmalonic, isovaleric). Obtain acylcarnitine/urine organic acids. IV carnitine, biotin, protein restriction.
  • πŸ”Ή Hypoglycemia + hypoketotic β†’ Fatty acid oxidation disorder (MCAD, VLCAD). Acylcarnitine, avoid fasting, IV glucose.
  • πŸ”Ή Hypoglycemia + ketotic + hepatomegaly β†’ Glycogen storage disease or gluconeogenesis defect.
  • πŸ”Ή Metabolic acidosis + normal ammonia + elevated lactate β†’ Pyruvate metabolism disorder, mitochondrial RC defect, or biotinidase deficiency.

Step 4: Advanced testing β€” Plasma amino acids, urine organic acids, acylcarnitine profile, enzyme assays, and/or genetic testing (exome/panel).

Step 5: Empiric management while awaiting results: IV dextrose (10% at 1.5Γ— maintenance), stop protein for 24h, IV carnitine (50–100 mg/kg), hemodialysis if NH3 > 500 ΞΌmol/L.

⚠️ Always rule out sepsis and acquired causes (e.g., valproate toxicity, liver failure).

🚩 Clinical Findings That Should Prompt a Metabolic Workup (Table 104.12)

SystemRed Flags
Family historyUnexplained sibling death, consanguinity, ethnic predisposition (e.g., Amish MSUD, French Canadian tyrosinemia), recurrent miscarriages
CNS / NeuromuscularProgressive encephalopathy, developmental regression, intractable seizures, hypotonia β†’ spasticity, dystonia, stroke-like episodes, ataxia, autism regression
Gastrointestinal / HepaticHepatomegaly, Reye-like syndrome, cholestasis, cirrhosis, recurrent vomiting, acute pancreatitis, failure to thrive
CardiacHypertrophic or dilated cardiomyopathy, arrhythmia, unexplained cardiac failure
RenalFanconi syndrome, nephrolithiasis, renal tubular acidosis, unexplained renal failure
OphthalmologicCherry-red spot (Tay-Sachs, Niemann-Pick, GM1), cataracts (galactosemia, CDG), corneal clouding (MPS, cystinosis), lens dislocation (homocystinuria)
DermatologicAngiokeratomas (Fabry, fucosidosis), alopecia (biotinidase), ichthyosis (multiple sulfatase deficiency, Refsum), abnormal hair (Menkes kinky hair)
HematologicUnexplained cytopenias, pancytopenia, hemophagocytosis, megaloblastic anemia (cobalamin disorders)

πŸ“Š Laboratory Findings That Should Prompt Metabolic Workup (Table 104.13 & text)

AbnormalityPossible IEM
HyperammonemiaUrea cycle defect, organic acidemia, fatty acid oxidation defect, transient hyperammonemia
Hypoglycemia (especially hypoketotic)Fatty acid oxidation, hyperinsulinism, GSD I, gluconeogenesis defect
Metabolic acidosis (high anion gap)Organic acidemia, lactic acidosis (mitochondrial, pyruvate defects), ketosis
Lactic acidosisMitochondrial RC defects, pyruvate dehydrogenase, pyruvate carboxylase, GSD I, biotinidase
Liver dysfunction + hypoglycemiaGalactosemia, tyrosinemia type I, hereditary fructose intolerance, GSD
Pancytopenia + acidosisPropionic / methylmalonic acidemia, Pearson syndrome

πŸ“Œ Additional Pearls: Any neonate with recurrent vomiting, lethargy, seizures and negative sepsis workup β€” obtain ammonia, lactate, urine ketones. OTC deficiency may present with respiratory alkalosis without acidosis. Premature infants: transient hyperammonemia can mimic UCD; treat aggressively but prognosis good.

⚑ Reflex Prompts: Physical Examination Clues to IEM (Table 104.10 style)

πŸ“– Additional Key Physical Findings (Nelson Table 104.10 selected)

FindingDisorders to Consider
MacrocephalyGlutaric aciduria type I, Canavan disease, Alexander disease, Tay-Sachs
MicrocephalyMitochondrial RC defects, serine synthesis defects, cblC deficiency, Smith-Lemli-Opitz
Coarse facial featuresMucopolysaccharidoses, oligosaccharidoses, GM1 gangliosidosis, I-cell disease
Cherry-red spotTay-Sachs, Sandhoff, Niemann-Pick type A, GM1 gangliosidosis, sialidosis
CataractsGalactosemia, CDG, Wilson disease, Zellweger, Lowe syndrome
Corneal cloudingMPS I, IV, VI, cystinosis, mucolipidoses, tyrosinemia type II
HepatosplenomegalyGaucher, Niemann-Pick, MPS, Wolman, CDG, glycolipidoses
Steely/kinky hairMenkes disease
Trichorrhexis nodosa (brittle hair)Argininosuccinic aciduria, biotinidase deficiency
Alopecia + rashMultiple carboxylase deficiency (biotinidase / holocarboxylase synthetase)